JAK2 and myeloproliferative neoplasm: Combination treatment of PV and primary MF CD34+ cells, followed by transplantation into immunodeficient mice, decreased the extent of donor-derived chimerism as well as the JAK2 V617F allele burden, suggesting that such combinatorial approaches may deplete MPN hematopoietic stem cells [170].